Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENVB | AMGN | VRTX | REGN | BMY |
| Company | Enveric Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9200 | 276.11 | 396.20 | 892.11 | 44.40 |
| High | 0.9498 | 276.12 | 396.69 | 896.48 | 44.76 |
| Low | 0.9200 | 272.35 | 392.50 | 885.01 | 43.97 |
| Last | 0.9400 | 273.14 | 394.70 | 893.28 | 44.61 |
| Change | -0.0098 | -3.24 | -1.50 | +0.80 | -0.03 |
| % Change | -1.03% | -1.17% | -0.38% | +0.09% | -0.07% |
| Volume | 72,998 | 377,361 | 166,583 | 108,738 | 4,161,731 |
| 20-Day Average Volume | 140,147 | 2,103,179 | 893,594 | 440,496 | 13,218,352 |
| Previous Close | 0.9498 | 276.38 | 396.20 | 892.48 | 44.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9256 | 269.58 | 399.34 | 911.66 | 48.65 |
| 20-Day Raw Stochastic | 43.41% | 87.01% | 16.02% | 21.50% | 6.65% |
| 20-Day Relative Strength | 47.42% | 50.37% | 40.64% | 38.13% | 28.53% |
| Weighted Alpha | -81.87 | +13.08 | +11.90 | +15.46 | -35.46 |
| Today's Opinion | 88% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 80% Sell | 24% Buy | 56% Buy | 96% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.76% since 04/23/24 | +0.45% since 04/23/24 | -2.49% since 04/23/24 | -1.48% since 04/23/24 | -8.98% since 04/23/24 |
| Low | 0.8800 on 04/25/24 | 265.72 on 04/26/24 | 392.50 on 04/30/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 0.9800 on 04/24/24 | 276.86 on 04/29/24 | 406.83 on 04/24/24 | 915.70 on 04/24/24 | 49.04 on 04/24/24 |
| 1-Month | |||||
| %Chg | -5.99% since 03/28/24 | -3.36% since 03/28/24 | -5.54% since 03/28/24 | -7.12% since 03/28/24 | -17.78% since 03/28/24 |
| Low | 0.8300 on 04/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 1.1900 on 04/02/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +17.51% since 01/30/24 | -12.67% since 01/30/24 | -11.49% since 01/30/24 | -6.86% since 01/30/24 | -9.72% since 01/30/24 |
| Low | 0.6490 on 02/01/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 2.9200 on 02/29/24 | 329.72 on 02/05/24 | 444.07 on 01/31/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -48.63% since 10/30/23 | +4.40% since 10/30/23 | +10.46% since 10/30/23 | +14.95% since 10/30/23 | -13.00% since 10/30/23 |
| Low | 0.6490 on 02/01/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.00 on 04/30/24 |
| High | 2.9200 on 02/29/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,928 | 148,243,600 | 102,401,456 | 97,960,392 | 90,489,744 |
| Shares Outstanding, K | 7,294 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -17,290,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -3,440,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.85 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 03/25/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 29.57 | 23.50 | 42.71 |